Plasma Circulating-microRNA Profiles Are Useful for Assessing Prognosis in Patients With Cytogenetically Normal Myelodysplastic Syndromes

Modern Pathology - United Kingdom
doi 10.1038/modpathol.2014.108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Microarray Profiling Defines Circulating microRNAs Associated With Myelodysplastic Syndromes

Neoplasma
Cancer Research
2017English

Improving Prognostic Tools for Patients With Myelodysplastic Syndromes

Mayo Clinic Proceedings
Medicine
2018English

The Myelodysplastic Syndromes: Diagnosis, Prognosis and Therapy

Italian Journal of Medicine
Medicine
2013English

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes Is Associated With Inferior Prognosis

Cancer
Cancer ResearchOncology
2017English

Hematopoietic Stem Cell Transplantation for Older Patients With Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Cellularity, Characteristics of Hematopoietic Parameters and Prognosis in Myelodysplastic Syndromes

European Journal of Haematology
MedicineHematology
2015English

Landscape of Genetic Lesions in 944 Patients With Myelodysplastic Syndromes

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma

PLoS ONE
Multidisciplinary
2016English

Low Expression of Circulating microRNA-328 Is Associated With Poor Prognosis in Patients With Acute Myeloid Leukemia

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy